Lassa fever resources
PPE washing and drying station Lassa ward Owo
ISARIC is committed to strengthening the evidence base for Lassa fever therapeutics and improving case management. We have initiated a number of activities to address these knowledge gaps, which are conducted alongside a wide-range of partners and collaborators.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Visit this section to find ISARIC’s articles, studies and more.
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data
“These regional differences in mortality reflect differences in access to better health care that already existed before the pandemic”, explains Fernando Bozza, study coordinator and researcher at the National Institute of Infectious Disease.
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
The QCOVID is a new risk prediction tool that uses readily available information about people, such as their age, ethnicity and whether they have certain comorbidities to help identify individuals at highest risk of developing severe illness.
“Genetic evidence is second only to clinical trials as a way to tell which treatments will be effective in a disease.”